Hemispherx Biopharma Inc (HEB)
24 Mar 2017
Thu, Jan 26 2017
* Hemispherx Biopharma Inc says order of newly manufactured Rintatolimod for sale utilizing early access program in Europe has been shipped Source text for Eikon: Further company coverage:
* Hemispherx Biopharma- On Jan. 3, entered into purchase order with Jubilant Hollister Stier, where Jubilant will manufacture commercial batch of Ampligen for co Source: (http://bit.ly/2ju230U) Further company coverage:
* Hemispherx Biopharma announces extension of Rintatolimod European early access program (eap) to pancreatic cancer patients Source text for Eikon: Further company coverage:
- InsiderInsights.com Daily Round Up 12/23/16: FOLD, GTE
- Hemispherx's (HEB) CEO Thomas Equels on Q3 2016 Results - Earnings Call Transcript
- Hemispherx's (HEB) CEO Tom Equels on Q1 2016 Results - Earnings Call Transcript
- Hemispherx Biopharma's (HEB) CEO William Carter on Q4 2016 Results - Earnings Call Transcript
- Can Hemispherx Get On Track After Its February Shake-Up?
- Are There Any Small Biotechnology Companies With An Answer To The Zika Virus Question?